ZNTL icon

Zentalis Pharmaceuticals

110 hedge funds and large institutions have $1.15B invested in Zentalis Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 9 closing their positions.

Holders
110
Holders Change
+4
Holders Change %
+3.77%
% of All Funds
1.76%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
13
Increased
40
Reduced
35
Closed
9
Calls
$608K
Puts
$471K
Net Calls
+$137K
Net Calls Change
-$1.42M
Name Market Value Shares Shares
Change
Shares
Change %
US Bancorp
101
US Bancorp
Minnesota
$8.08K 470 +442 +1,579%
LC
102
Lindbrook Capital
California
$7.16K 416 +408 +5,100%
Daiwa Securities Group
103
Daiwa Securities Group
Japan
$4K 212
TWA
104
TCI Wealth Advisors
Arizona
$3.32K 193 +193 New
CFGS
105
Concourse Financial Group Securities
Alabama
$1.72K 100
QCG
106
Quadrant Capital Group
Ohio
$1.53K 89
BIA
107
Bell Investment Advisors
California
$1.31K 76
S
108
SignatureFD
Georgia
$1.29K 75
OM
109
Opaleye Management
Massachusetts
-167,500 Closed
CS
110
Candriam SCA
Luxembourg
-127,973 Closed
GTCM
111
Gyon Technologies Capital Management
New Jersey
-42,905 Closed
Tudor Investment Corp
112
Tudor Investment Corp
Connecticut
-20,054 Closed
QT
113
Quantbot Technologies
New York
-13,600 Closed
ProShare Advisors
114
ProShare Advisors
Maryland
-10,759 Closed
Rockefeller Capital Management
115
Rockefeller Capital Management
New York
-288 Closed
BTI
116
Blue Trust Inc
Georgia
$0 16 -37 -70%
NA
117
NewEdge Advisors
Louisiana
-10 Closed
AF
118
Allworth Financial
California
-9 Closed
Group One Trading
119
Group One Trading
Illinois
Simplex Trading
120
Simplex Trading
Illinois
JGC
121
J. Goldman & Co
New York
C
122
Covestor
United Kingdom
$0 5